Synthetically vs. Naturally Derived Cannabinoids

There is a high demand for extracts containing phytocannabinoids derived from Industrial Hemp. However, there are two major molecular limitations, related to the biology of the plant itself, that make these extracts difficult to produce commercially. 

The first is a generally low cannabinoid percentage / dry weight ratio. Since the average cannabidiol percentage in Industrial Hemp (EU certified genetics) is only around 2-4%, and minor cannabinoid percentage is around 0-1%, manufacturers must use large scale extraction procedures to produce extracts. This limitation has pushed some manufacturers to search for alternative methods for producing these cannabinoids, especially for those which are present in the lowest concentrations (CBN, CBC, etc.). 

The second is the presence of THC. Due to THC’s status as a schedule substance, manufacturers must figure out how to produce CBD extracts with compliant levels of THC. This challenge has also resulted in manufacturers turning to alternative methods, whether it be new technology, simple dilution, or chemical modification to produce extracts below the THC threshold.

While manufacturers scramble to produce these extracts legally and at lower costs, consumers are left in the dark about what is going on behind the scenes. Although the majority of consumers assume they are purchasing products which contain cannabinoids that occur naturally in Industrial Hemp, it is very common for many of these products to contain cannabinoids that have been artificially produced or chemically modified from Industrial Hemp derivatives after extraction. 

Therefore, the industry must hold itself accountable with consumers and make a clear distinction between cannabinoids which occur naturally in hemp, and cannabinoids which undergo deliberate chemical modification, including synthetic cannabinoids.

NATURALLY OCCURRING CANNABINOIDS

Industrial Hemp provides a biomass that contains an average of 2-4% cannabinoids by dry weight, the majority of which is CBD. Another important cannabinoid, often with relatively high concentrations, is THC, which by law must be below 0.2% by weight.

In addition to CBD and THC, there are also minor cannabinoids, which are typically present in relatively low concentrations (< 1%). Of the ones that have been identified, these minor cannabinoids include CBG, CBN, and CBC.

Many of these cannabinoids are related to one another in their natural synthesis process. For example, when THC is exposed to light and heat, it converts to CBN. This is a process that occurs naturally over time in the plant in the hemp field as the THC begins to degrade. However, some manufacturers have deliberately leveraged this natural process in order to subvert THC regulations.

CANNABINOIDS THAT UNDERGO DELIBERATE CHEMICAL MODIFICATION

Keeping THC within legal limits is a major challenge in the CBD industry, as manufacturers do not have the technology or know-how to remove THC. Instead of purification or separation science, most processors have turned to ‘cooking’ their extracts in order to chemically convert THC.

Here’s how it works: By introducing the hemp extract to heat and oxygen, the THC will undergo a chemical conversion. ‘Cooking’ hemp extracts is a method used in the industry to chemically modify the non-compliant THC found in the CBD oil and turn it into the cannabinoid derivative CBN. 

This process should not be described as extraction or purification, rather, it is more accurately described as a chemical reaction. Not only is the THC subject to this process, but the entire extract is ‘cooked’, meaning this reaction is likely affecting other cannabinoids and molecules in the extract as well. The reason this is a problem is because manufacturers are not disclosing these processes to consumers.

Cannabinoids that have been chemically modified after extraction should not be described as ‘hemp derived’. Although the precursor molecules may have been derived from Industrial Hemp, the final product was produced through an alternative chemical process, and consumers deserve to be aware of that.

 THE DANGERS OF SYNTHETIC CANNABINOIDS

In addition to the chemical modification of cannabinoids like THC, there is another unnatural method for creating cannabinoids, which is the production of synthetic cannabinoids. Synthetic cannabinoids are the opposite of naturally derived cannabinoids, because they are created in a laboratory. Although there is nothing inherently wrong with synthetic cannabinoid production, the problem lies in consumer awareness and lack of clinical testing. Customers should be informed if they are consuming synthetic cannabinoids, and it is the responsibility of manufacturers to be transparent about this.

The risks of consuming synthetically derived compounds is well documented in the pharmaceutical world, but it is also well documented in the cannabinoid industry. The most infamous synthetic cannabinoids are K2 and Spice, which are psychoactive, synthetic cannabinoids made known for their adverse health effects before they were outlawed.

Synthetic production of cannabinoids without complete characterization of the finished extract is also risky. A natural extract from the Industrial Hemp plant contains a single enantiomer of THC (- delta 9 THC), while a synthetically produced extract contains both the + and – enantiomers. Since the synthetic form does not exist in nature, it may interact with the human body in a unique and potentially harmful way. For this reason, manufacturers should disclose whether or not they are using synthetic cannabinoids.

The reason synthetic compounds are potentially dangerous is because “The human body is not equipped with the tools needed to catabolize synthetic cannabinoids.” Novel cannabinoid molecules created through synthesis are chemically very different from their naturally derived counterparts. This means that the human body does not have the appropriate enzymes to break them down, which could be very dangerous.

There are multiple reports and studies about adverse health effects of synthetic cannabinoids found in CBD products on the market. This study investigates 50+ cases associated with a CBD product in the USA that contained a synthetic cannabinoid. This report analyzes the case where an epileptic child was poisoned by a CBD product which contained a synthetic cannabinoid. In both of these instances, consumers were completely unaware that there were synthetic compounds in the products they purchased. 

BIOSYYD IS KEEPING IT NATURAL

At Biosyyd, we never use synthetic compounds or processes to chemically modify our cannabinoids. We believe in the importance of extracting and purifying the naturally occurring compounds in Industrial Hemp, as well as removing impurities and THC through separation science, not chemical modification.

Our process is conducted without extreme temperature or pressure. Extracting and purifying our oils at gentle temperatures ensures minimal degradation and damage to the natural cannabinoids and terpenes. 

Consumers should not have to question whether or not their CBD was actually derived from Industrial Hemp. That is why we uphold the integrity of our hemp derived cannabinoids. We believe that everyone deserves access to safe, traceable, high quality, and naturally derived cannabinoids. 

Consider this a public service announcement for the consumers of CBD. After all, every consumer deserves to know what they are putting in their body. As industry leaders, it is our duty to demystify CBD for consumers.